TOtal tRansfemoral branCHed endovasCular tHoracoabdominal Aortic Repair Registry

IRCCS San Raffaele100 enrolled

Overview

The purpose of the registry is to evaluate the peri-operative, short-, and mid- outcomes of endovascular treatment of thoracoabdominal aneurysms with multibranched endografts via total transfemoral approach for visceral vessels cannulation using steerable sheaths

Study Type

OBSERVATIONAL

Enrollment

100

Conditions

Aortic Aneurysm, Abdominal Aortic Aneurysm, Thoracic

Interventions

Steerable introducersDEVICE

endografts via total transfemoral approach for visceral vessels cannulation

Eligibility

Sex: ALLMin age: 18 Years

Medical Language ↔ Plain English

Inclusion Criteria: * patient adult ( ≥18 years) of either sex, * patients who underwent a complex aortic procedure requiring a branched endograft via total transfemoral approach in the centers involved in the TORCH2 Registry Exclusion Criteria: * patients who did not receive treatment via total transfemoral approach, * patient with bleeding diathesis or coagulopathy, * patients with active systemic or cutaneous infection or inflammation, * patients who are pregnant or lactating, * patient younger than 18 years of age. * Absence of at least one imaging follow-up within the first post-operative year

Locations (7)

IRCCS Ospedale San Raffaele

Milan, Lombardy, Italy

Policlinico S. Orsola Malpighi

Bologna, Italy

Azienda Universitaria Giuliano Isontina

Cattinara, Italy

Ospedale Policlinico San Martino

Genova, Italy

Outcomes

Primary Outcomes

technical success

successful bridging stent graft deployment of all vessels, with aneurysm exclusion, without any signs of type I or type III endoleak, and with no evidence of stenosis/occlusion and mating stent dislocation/kinking at intraoperative completion angiography.

Time frame: 30 days

branch instability

freedom from any branch related complications and/or required reinterventions

Time frame: 30 days

clinical success

absence of death, type I/III endoleak, graft infection/thrombosis, aneurysm expansion and/or rupture, conversion to open repair, or new treatment-related thoracoabdominal pathologies

Time frame: 30 days

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.